HQH Abrdn Healthcare Investors logo

HQH Abrdn Healthcare Investors

Financial Services
$19.47-0.61%ClosedMarket Cap: $1.11B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

10.31

PEG

0.01

P/B

0.98

P/S

49.50

EV/EBITDA

6.42

DCF Value

$13.34

FCF Yield

0.8%

Div Yield

11.9%

Margins & Returns

Gross Margin

77.2%

Operating Margin

770.3%

Net Margin

1150.1%

ROE

24.0%

ROA

23.6%

ROIC

15.8%

Financials

View All
PeriodRevenueNet IncomeEPS
FY null$99.8M$98.6M$
Q4 null$17.0M$173.4M$
FY 2025$99.8M$98.6M$1.84
Q4 null$5.5M$85.2M$

Analyst Ratings

View All

Consensus

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Reilly Heather Carterofficer
SellFri Dec 19
Dietrick Joseph Francis
SellTue Jul 22
Taggart Michaelofficer
SellThu Mar 20
Marsico Michaelofficer
SellThu Mar 20
Kim Andrew Wonilofficer
SellThu Mar 20

Company Info

Sector

Financial Services

Industry

Asset Management

Country

US

Exchange

Beta

0.77

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Peers